| # | Title | Journal | Year | Citations |
|---|
| 1 | Indications for Propensity Scores and Review of their Use in Pharmacoepidemiology | Basic and Clinical Pharmacology and Toxicology | 2006 | 474 |
| 2 | Antidepressants in the Treatment of Neuropathic Pain | Basic and Clinical Pharmacology and Toxicology | 2005 | 472 |
| 3 | Bibliometric Methods: Pitfalls and Possibilities | Basic and Clinical Pharmacology and Toxicology | 2005 | 471 |
| 4 | The Nordic Countries as a Cohort for Pharmacoepidemiological Research | Basic and Clinical Pharmacology and Toxicology | 2010 | 460 |
| 5 | Antihyperglycaemic and Antioxidant Effect of Rutin, a Polyphenolic Flavonoid, in Streptozotocin-Induced Diabetic Wistar Rats | Basic and Clinical Pharmacology and Toxicology | 2006 | 392 |
| 6 | Developmental Origins of Health and Disease: New Insights | Basic and Clinical Pharmacology and Toxicology | 2008 | 307 |
| 7 | Veterinary Drug Usage and Antimicrobial Resistance in Bacteria of Animal Origin | Basic and Clinical Pharmacology and Toxicology | 2005 | 299 |
| 8 | Comparison of Early and Late Toxic Effects of Sulfur Mustard in Iranian Veterans | Basic and Clinical Pharmacology and Toxicology | 2006 | 276 |
| 9 | Gastric Juice: A Barrier Against Infectious Diseases | Basic and Clinical Pharmacology and Toxicology | 2005 | 264 |
| 10 | How Palatable Food Disrupts Appetite Regulation | Basic and Clinical Pharmacology and Toxicology | 2005 | 256 |
| 11 | Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studies | Basic and Clinical Pharmacology and Toxicology | 2018 | 256 |
| 12 | Mucus as a Barrier to Drug Delivery – Understanding and Mimicking the Barrier Properties | Basic and Clinical Pharmacology and Toxicology | 2015 | 248 |
| 13 | BCPT policy for experimental and clinical studies | Basic and Clinical Pharmacology and Toxicology | 2021 | 248 |
| 14 | Reactive Oxygen Species and Endothelial Function – Role of Nitric Oxide Synthase Uncoupling and Nox Family Nicotinamide Adenine Dinucleotide Phosphate Oxidases | Basic and Clinical Pharmacology and Toxicology | 2012 | 242 |
| 15 | Health Effects of Early Life Exposure to Arsenic | Basic and Clinical Pharmacology and Toxicology | 2008 | 235 |
| 16 | Assessing Intrauterine Influences on Offspring Health Outcomes: Can Epidemiological Studies Yield Robust Findings? | Basic and Clinical Pharmacology and Toxicology | 2008 | 235 |
| 17 | Metabolic Drug Interactions with Newer Antipsychotics: A Comparative Review | Basic and Clinical Pharmacology and Toxicology | 2007 | 223 |
| 18 | Assessment of CYP1A2 Activity in Clinical Practice: Why, How, and When? | Basic and Clinical Pharmacology and Toxicology | 2005 | 222 |
| 19 | The Alkaline Comet Assay: Towards Validation in Biomonitoring of DNA Damaging Exposures | Basic and Clinical Pharmacology and Toxicology | 2006 | 222 |
| 20 | Comparison of Dynamic Treatment Regimes via Inverse Probability Weighting | Basic and Clinical Pharmacology and Toxicology | 2006 | 210 |
| 21 | Mesenchymal Stem Cells: Cell Biology and Potential Use in Therapy | Basic and Clinical Pharmacology and Toxicology | 2004 | 207 |
| 22 | Sex Differences in Animal Models of Depression and Antidepressant Response | Basic and Clinical Pharmacology and Toxicology | 2010 | 207 |
| 23 | Developmental Origins of Adult Health and Disease: The Role of Periconceptional and Foetal Nutrition | Basic and Clinical Pharmacology and Toxicology | 2008 | 206 |
| 24 | Ambient Air Pollution and Adverse Birth Outcomes: Methodologic Issues in an Emerging Field | Basic and Clinical Pharmacology and Toxicology | 2008 | 204 |
| 25 | Prenatal Exposures to Persistent and Non‐Persistent Organic Compounds and Effects on Immune System Development | Basic and Clinical Pharmacology and Toxicology | 2008 | 203 |
| 26 | Non-Steroidal Antiinflammatory Drugs and the Risk of Acute Myocardial Infarction | Basic and Clinical Pharmacology and Toxicology | 2006 | 194 |
| 27 | Anti‐inflammatory Effect of Rosmarinic Acid and an Extract of Rosmarinus officinalis in Rat Models of Local and Systemic Inflammation | Basic and Clinical Pharmacology and Toxicology | 2015 | 193 |
| 28 | The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm | Basic and Clinical Pharmacology and Toxicology | 2011 | 185 |
| 29 | Differential Inhibitory Effects of the Polyphenol Ellagic Acid on Inflammatory Mediators NF‐κB, iNOS, COX‐2, TNF‐α, and IL‐6 in 1,2‐Dimethylhydrazine‐Induced Rat Colon Carcinogenesis | Basic and Clinical Pharmacology and Toxicology | 2010 | 184 |
| 30 | Bioassay‐guided Evaluation of Antioxidant and Antinociceptive Activities of Carvacrol | Basic and Clinical Pharmacology and Toxicology | 2010 | 174 |
| 31 | Emerging Roles of Anacardic Acid and Its Derivatives: A Pharmacological Overview | Basic and Clinical Pharmacology and Toxicology | 2012 | 174 |
| 32 | Curcumin, both Histone Deacetylase and p300/CBP‐Specific Inhibitor, Represses the Activity of Nuclear Factor Kappa B and Notch 1 in Raji Cells | Basic and Clinical Pharmacology and Toxicology | 2007 | 168 |
| 33 | Pesticide Toxicity and the Developing Brain | Basic and Clinical Pharmacology and Toxicology | 2008 | 167 |
| 34 | Perinatal Exposure to Oestradiol and Bisphenol A Alters the Prostate Epigenome and Increases Susceptibility to Carcinogenesis | Basic and Clinical Pharmacology and Toxicology | 2008 | 165 |
| 35 | The Impact of Clinical Pharmacists on Drug‐Related Problems and Clinical Outcomes | Basic and Clinical Pharmacology and Toxicology | 2008 | 165 |
| 36 | The Faroes Statement: Human Health Effects of Developmental Exposure to Chemicals in Our Environment | Basic and Clinical Pharmacology and Toxicology | 2008 | 164 |
| 37 | In vivo Biology and Toxicology of Fullerenes and Their Derivatives | Basic and Clinical Pharmacology and Toxicology | 2008 | 155 |
| 38 | The First Decade with the Swedish Prescribed Drug Register – A Systematic Review of the Output in the Scientific Literature | Basic and Clinical Pharmacology and Toxicology | 2016 | 153 |
| 39 | Metabolism of Repaglinide by CYP2C8 and CYP3A4 in vitro: Effect of Fibrates and Rifampicin | Basic and Clinical Pharmacology and Toxicology | 2005 | 149 |
| 40 | Cyclodextrin‐Based Formulations: A Non‐Invasive Platform for Targeted Drug Delivery | Basic and Clinical Pharmacology and Toxicology | 2018 | 141 |
| 41 | CYP2C19Polymorphism and Proton Pump Inhibitors | Basic and Clinical Pharmacology and Toxicology | 2004 | 138 |
| 42 | Serious Anaphylactic Reactions due to Protamine Sulfate: A Systematic Literature Review | Basic and Clinical Pharmacology and Toxicology | 2008 | 137 |
| 43 | Non‐Steroidal Anti‐Inflammatory Drugs, Cyclooxygenase‐2 and the Bone Healing Process | Basic and Clinical Pharmacology and Toxicology | 2008 | 136 |
| 44 | Does Breast Cancer Start in the Womb? | Basic and Clinical Pharmacology and Toxicology | 2008 | 136 |
| 45 | Protective Effects of Ethanolic Extract of Zingiber officinale Rhizome on the Development of Metabolic Syndrome in High‐Fat Diet‐Fed Rats | Basic and Clinical Pharmacology and Toxicology | 2009 | 133 |
| 46 | Small Artery Remodelling in Hypertension | Basic and Clinical Pharmacology and Toxicology | 2012 | 132 |
| 47 | Endocrine Disruptors and Abnormalities of Pubertal Development | Basic and Clinical Pharmacology and Toxicology | 2008 | 131 |
| 48 | Antioxidant Activity of Limonene on Normal Murine Lymphocytes: Relation to H2O2 Modulation and Cell Proliferation | Basic and Clinical Pharmacology and Toxicology | 2010 | 131 |
| 49 | Medication Reviews by Clinical Pharmacists at Hospitals Lead to Improved Patient Outcomes: A Systematic Review | Basic and Clinical Pharmacology and Toxicology | 2013 | 128 |
| 50 | Pioglitazone is Metabolised by CYP2C8 and CYP3A4 in vitro: Potential for Interactions with CYP2C8 Inhibitors | Basic and Clinical Pharmacology and Toxicology | 2006 | 123 |
